Gratus Capital LLC Infinity Pharmaceuticals, Inc. Transaction History

Gratus Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$0.46 - $1.21 $34,201 - $89,963	74,350 Added 5.95%	1,323,598 $0
Q3 2022 Nov 03, 2022	BUY	$0.59 - $1.7 $77,935 - $224,559	132,094 Added 11.82%	1,249,248 $1.49 Million
Q2 2022 Jul 29, 2022	BUY	$0.49 - $1.2 $42,017 - $102,900	85,750 Added 8.31%	1,117,154 $706,000
Q1 2022 Apr 29, 2022	BUY	$0.85 - $2.4 $63,352 - $178,876	74,532 Added 7.79%	1,031,404 $1.18 Million
Q4 2021 Jan 31, 2022	BUY	$1.86 - $3.36 $1.78 Million - $3.22 Million	956,872 New	956,872 $2.15 Million

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Gratus Capital LLC with notifications on news.